FLT3 and acute myeloid leukemia: Foretinib directly bound to FLT3, effectively inhibiting its signaling pathway, resulting in potent anti-proliferative and pro-apoptotic effects in AML cell lines and primary AML cells harboring FLT3-ITD mutations.